When discussing administration, talk to your doctor about your location options
REBYOTA administration in your doctor’s office
REBYOTA can be administered right in your doctor’s office once you’ve completed your course of antibiotics. After administration, there is a 15-minute wait period, after which you can go home.
REBYOTA @ Home
If you are unable to receive REBYOTA in your doctor’s office, you may benefit from the option of administration via home health in the comfort of your home.
Getting ready for administration with REBYOTA1
BEFORE ADMINISTRATION
No preparation is required
- You should complete your antibiotic prescription 1 to 3 days before your REBYOTA administration appointment
- No laxatives/bowel prep or fasting are required
DURING ADMINISTRATION
Takes place within minutes
- Anesthesia or colonoscopy are not necessary
- The doctor or nurse will place you in the preferred position for the administration
- You will be asked to remain in place for about 15 minutes to minimize any cramping that may occur
AFTER ADMINISTRATION
Follow your doctor’s instruction
Talk to your doctor…
- If you experience any side effects
- Before taking antibiotics for any reason for 8 weeks after administration of REBYOTA
Most common side effects may include stomach pain, diarrhea, bloating, gas, and nausea.1 These side effects could occur during the first 2 weeks after administration.1 This may not mean your recurrent C. diff has come back.
Your REBYOTA Experience
Watch as a nurse shows you what to expect before, during, and after administration with REBYOTA.
REBYOTA is available by prescription only. Talk to your doctor to find out if REBYOTA is right for you.
Candace, RN, CCRP, was compensated for her time.
Talking to your doctor about recurrent C. diff and potential therapy options
Create your own customized discussion guide
Answering these questions will help you prepare for a conversation about C. diff with your doctor. This information is completely confidential and will not be saved for other use.
REBYOTA administration FAQs
Here are answers to general questions regarding REBYOTA.
Before administration
During administration
After administration
REBYOTA @ HOME
Keep exploring REBYOTA
Sign up for more information
Receive additional information and resources to help you through your C. diff infection journey.
Reference
- REBYOTA. Prescribing Information. Parsippany, NJ: Ferring Pharmaceuticals Inc; 2022.
Please see Important Safety Information and full Prescribing Information
INDICATION
REBYOTA (fecal microbiota, live – jslm) is indicated for the prevention of recurrence of Clostridioides difficile (C. diff) infection in individuals 18 years of age and older, following antibiotic treatment for recurrent C. diff infection.
Limitation of Use
REBYOTA is not indicated for the treatment of C. diff infection.
Important Safety Information
- You should not receive REBYOTA if you have a history of a severe allergic reaction (e.g., anaphylaxis) to REBYOTA or any of its components.
- You should report to your doctor any infection you think you may have acquired after administration.
- REBYOTA may contain food allergens.
- Most common side effects may include stomach pain (8.9%), diarrhea (7.2%), bloating (3.9%), gas (3.3%), and nausea (3.3%).
- REBYOTA has not been studied in patients below 18 years of age.
- Clinical studies did not determine if adults 65 years of age and older responded differently than younger adults.
You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-332-1088.
Please click to see the full Prescribing Information.